2161: JBM (Healthcare) Limited - Summary | Jitta

JBM (Healthcare) Limited

HKG:2161

Price
HK$2.48
Loss Chance
41.2%
7.32JITTA SCORE
65.01%Under Jitta Line
Jitta Ranking
16 / 225
177 / 2,478
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (78)
Recent Business Performance (86)
Financial Strength (83)
Return to Shareholders (55)
Competitive Advantage (70)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 3 years
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
7.32
65.01%
4.29
286.37%
3.71
298.72%
Pharmaceuticals
6.49
316.37%
7.55
158.05%
5.59
298.00%
COMPANY DESCRIPTION
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and CCMG products. It is also involved in the manufactures, trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.